Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1808
| Despition | LIF Human Recombinant, Yeast Tag |
| SIZE | 5 µg |
| Purity | > 98.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1374 | Human Ephrin A4 Protein (AC1374) | 2 µg | inquiry |
| ACPP-1334 | DRP1 Blocking Peptide (AC1334) | 250 µg | inquiry |
| ACPP-1626 | Human SHC1 Protein (AC1626) | 5 µg | inquiry |
| ACPP-1394 | Human BPNT1 Protein (AC1394) | 2 µg | inquiry |
| ACPP-1080 | GABA B Receptor 2 Blocking Peptide (AC1080) | 250 µg | inquiry |
| ACPP-1485 | Rat VEGF C Protein (152 a.a.) (AC1485) | 2 µg | inquiry |
| ACPP-1031 | Recombinant Human CD24 Protein (Fc Tag) (AC1031) | 50 µg | inquiry |
| ACPP-1803 | Human KISS1 Protein (AC1803) | 2 µg | inquiry |
| ACPP-1450 | Human BMP13 Protein (AC1450) | 10 µg | inquiry |
| ACPP-1828 | Human EPHA2 Protein (AC1828) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.